These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9676908)

  • 21. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
    Arimoto A; Kitagawa K; Mita N; Takahashi Y; Shibuya E; Sasaki H
    Cornea; 2014 Aug; 33(8):806-11. PubMed ID: 24977983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group.
    Nelson JD; Gordon JF
    Am J Ophthalmol; 1992 Oct; 114(4):441-7. PubMed ID: 1415455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
    Perényi K; Dienes L; Kornafeld A; Kovács B; Kiss HJ; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
    J Ocul Pharmacol Ther; 2017; 33(6):487-492. PubMed ID: 28375789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the severity of keratitis sicca with videokeratoscopic indices.
    de Paiva CS; Lindsey JL; Pflugfelder SC
    Ophthalmology; 2003 Jun; 110(6):1102-9. PubMed ID: 12799233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial.
    Sand BB; Marner K; Norn MS
    Acta Ophthalmol (Copenh); 1989 Apr; 67(2):181-3. PubMed ID: 2658462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular surface changes in keratoconjunctivitis sicca with silicone punctum plug occlusion.
    Dursun D; Ertan A; Bilezikçi B; Akova YA; Pelit A
    Curr Eye Res; 2003 May; 26(5):263-9. PubMed ID: 12854053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy].
    Safonova TN; Gladkova OV; Boev VI; Fedorov AA
    Vestn Oftalmol; 2016; 132(5):39-48. PubMed ID: 27911424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast sensitivity and tear layer aberrometry in dry eye patients.
    Ridder WH; LaMotte J; Hall JQ; Sinn R; Nguyen AL; Abufarie L
    Optom Vis Sci; 2009 Sep; 86(9):E1059-68. PubMed ID: 19648840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of tear films tests in type 2 diabetes.
    Rahman A; Yahya K; Ahmed T; Sharif-Ul-Hasan K
    J Pak Med Assoc; 2007 Dec; 57(12):577-81. PubMed ID: 18173037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of keratoconjunctivitis sicca in rabbits with 3-isobutyl-1-methylxanthine.
    Gilbard JP
    Arch Ophthalmol; 1994 Dec; 112(12):1614-6. PubMed ID: 7527631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased tear evaporation in eyes with keratoconjunctivitis sicca.
    Rolando M; Refojo MF; Kenyon KR
    Arch Ophthalmol; 1983 Apr; 101(4):557-8. PubMed ID: 6838413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tear film osmolarity measurements in dry eye disease using electrical impedance technology.
    Jacobi C; Jacobi A; Kruse FE; Cursiefen C
    Cornea; 2011 Dec; 30(12):1289-92. PubMed ID: 22001814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials.
    Wu D; Chen WQ; Li R; Wang Y
    Cornea; 2015 Jun; 34(6):644-50. PubMed ID: 25909234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of laser confocal tomography in diagnosis and monitoring of keratoconjunctivitis sicca].
    Safonova TN; Gladkova ОV; Boev VI
    Vestn Oftalmol; 2016; 132(2):47-54. PubMed ID: 27213797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
    Lekhanont K; Park CY; Smith JA; Combs JC; Preechawat P; Suwan-Apichon O; Rangsin R; Chuck RS
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):27-34. PubMed ID: 17341147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
    Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
    Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ocular surface in keratoconjunctivitis sicca.
    Bron AJ; Mengher LS
    Eye (Lond); 1989; 3 ( Pt 4)():428-37. PubMed ID: 2606217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact on ocular surface evaporation of an artificial tear solution containing hydroxypropyl guar.
    Uchiyama E; Di Pascuale MA; Butovich IA; McCulley JP
    Eye Contact Lens; 2008 Nov; 34(6):331-4. PubMed ID: 18997543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of artificial tear application on contrast sensitivity in dry and normal eyes.
    Akin T; Karadayi K; Aykan U; Certel I; Bilge AH
    Eur J Ophthalmol; 2006; 16(6):785-90. PubMed ID: 17191182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.